PRODUCT LITERATURE

Comparison of Cefdinir and Cefaclor in Treatment of Community-Acquired Pneumonia

---

Six hundred ninety patients were enrolled in a multicenter, randomized, double-blind trial comparing the
efficacy and safety of cefdinir with those of cefaclor in the treatment of community-acquired pneumonia.
Patients received either 10 days of treatment with cefdinir (n 5 347) at 300 mg twice daily or 10 days of
treatment with cefaclor (n 5 343) at 500 mg three times daily. Microbiological assessments were performed on
sputum specimens obtained at admission and at the two posttherapy visits, if available

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Omnicef

Specific Detail Info

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1997, p. 1579–1583

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment